We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

INTEGRA BIOSCIENCES AG

Automated Immunoassay Enables Management of High Vitamin D Workloads

By LabMedica International staff writers
Posted on 12 Jul 2012
Laboratories in the United Kingdom have adopted a new automated immunoassay for increasing vitamin D workloads.

The fast and accurate immunoassay for circulating 25-hydroxy vitamin D (25(OH)D) provides a reliable indication of vitamin D status and ensures faster turnaround of results.

The Elecsys vitamin D total assay has helped The Doctors Laboratory (TDL) Whitfield Street Laboratory (London, United Kingdom) to deal with extremely high workloads of around 3,000 vitamin D assays per week.

Recent news coverage in the UK has highlighted the increasing number of people suffering vitamin D deficiency–ranging from children who play less outside and are therefore exposed less to sunlight, to pregnant women and the elderly–population groups where the regulation of calcium and other nutrients required for strong healthy bones is most vital. Laboratories are consequently experiencing increased demand for vitamin D testing.

The Elecsys vitamin D Total assay is available for both Roche (Basel, Switzerland) Modular and cobas analytical platforms. It detects the 25(OH) metabolite of both vitamin D2 and vitamin D3 in serum or plasma, ensuring an accurate indication of vitamin D status. This assay has been standardized against the Liquid chromatography–Mass spectrometry/ Liquid chromatography-Mass spectrometry (LC-MS/MS) reference method and demonstrates good functional sensitivity (<5 ng/mL) and precision, particularly at lower levels, making it ideal for effective patient management.

The launch of the Elecsys vitamin D total assay allows Roche to offer one of the most complete bone marker assay menus available on a single platform. Together with the Elecsys assays for ß Crosslaps, Serum procollagen type 1 amino- terminal propeptide (P1NP), Osteocalcin, and parathyroid hormone (PTH), this allows a complete differential diagnosis of bone metabolism in patients at risk of, or having bone disease.

Related Links:

The Doctors Laboratory Whitfield Street Laboratory
Roche



Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
6 Part Hematology Analyzer with RET + IPF
Mispa HX 88
Laboratory Software
ArtelWare

Latest Clinical Chem. News

New Blood Test Index Offers Earlier Detection of Liver Scarring
12 Jul 2012  |   Clinical Chem.

Electronic Nose Smells Early Signs of Ovarian Cancer in Blood
12 Jul 2012  |   Clinical Chem.

Simple Blood Test Offers New Path to Alzheimer’s Assessment in Primary Care
12 Jul 2012  |   Clinical Chem.